Oramed Pharmaceuticals, Inc. (ORMP)
2.93
-0.05
(-1.68%)
USD |
NASDAQ |
Dec 19, 16:00
2.90
-0.03
(-1.02%)
Pre-Market: 20:00
Oramed Pharmaceuticals Market Cap: 116.62M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 667.86M |
| Palatin Technologies, Inc. | 15.85M |
| Theriva Biologics, Inc. | 6.434M |
| Oragenics, Inc. | 0.7223M |
| NanoViricides, Inc. | 22.32M |
Market Cap Related Metrics
| PE Ratio | 2.922 |
| PS Ratio | 60.99 |
| PEG Ratio | 0.0036 |
| Price to Book Value | 0.5737 |
| Price | 2.93 |
| Earnings Yield | 34.22% |
| PEGY Ratio | 0.0036 |
| Normalized PE Ratio | 5.244 |